ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,768Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 134

$582K Total Retail Price of All Prescriptions

Rank: 23 out of 134

497 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,082 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 633 518 1 1
HYDROCODONE-ACETAMINOPHEN 600 357 S3 2 5
WARFARIN SODIUM 398 327 3 8
SIMVASTATIN 357 261 4 2
POTASSIUM CHLORIDE 354 272 5 10
FUROSEMIDE 344 248 6 7
OMEPRAZOLE 343 230 7 3
METFORMIN HCL 288 206 8 9
LISINOPRIL 287 192 9 4
LOSARTAN POTASSIUM 256 201 10 11
TRAZODONE HCL 237 167 11 23
FENTANYL 218 174 S2 12 41
GABAPENTIN 214 160 13 12
SERTRALINE HCL 212 186 14 24
PREDNISONE 195 147 15 28
CITALOPRAM HBR 175 146 16 14
ATENOLOL 166 146 17 19
AMLODIPINE BESYLATE 160 147 18 6
METOPROLOL TARTRATE 151 122 19 17
TRIAMTERENE-HCTZ 125 112 20 40
HYDROCHLOROTHIAZIDE 125 94 20 13
SPIRONOLACTONE 122 94 22 29
DIGOXIN 117 88 23 31
LANTUS 114 81 24 32
DONEPEZIL HCL 106 106 25 30
CYCLOBENZAPRINE HCL 102 36 R 26 93
ALENDRONATE SODIUM 101 96 27 21
TRAMADOL HCL 99 27 28 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 62 29 127
DIVALPROEX SODIUM 94 69 30 96
KLOR-CON M20 93 70 31 92
TAMSULOSIN HCL 90 85 32 26
METOPROLOL SUCCINATE 86 73 33 16
PAROXETINE HCL 82 77 34 46
PROAIR HFA 79 34 35 49
ZOLPIDEM TARTRATE 76 39 36 15
ATORVASTATIN CALCIUM 74 65 37 18
AZITHROMYCIN 73 44 38 78
ENALAPRIL MALEATE 71 55 39 80
FLUTICASONE PROPIONATE 71 56 39 34
HYDROMORPHONE HCL 69 29 S2 41 175
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 55 41 45
PROPRANOLOL HCL 68 68 43 102
AMITRIPTYLINE HCL 64 30 R 44 51
NEXIUM 64 47 44 54
FLUOXETINE HCL 64 36 44 42
RISPERIDONE 64 38 44 67
METHADONE HCL 63 28 S2 48 83
BUPROPION HCL SR 60 38 49 148
CARVEDILOL 59 53 50 27
NOVOLOG 58 20 51 72
LANTUS SOLOSTAR 57 33 52 62
NORTRIPTYLINE HCL 56 50 53 223
BUPROPION XL 56 31 53 108
CLOPIDOGREL 54 41 55 52
MORPHINE SULFATE ER 51 0 S2 56 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.